Propanc Biopharma gets Nasdaq bid price deficiency noticeOct 29Exchange listingPropanc Biopharma, Inc.
Neogen raises fiscal 2027 revenue, EBITDA outlook on first-quarter growthOct 21Clinical readoutAbbott LaboratoriesargenxUpdated
Propanc Biopharma's S-1 details 1:25 reverse split and Hexstone resale termsJul 17FinancingPropanc Biopharma, Inc.
Propanc Biopharma board member departs, accountant Carlo Campiciano appointed to replace herJul 14PeoplePropanc Biopharma, Inc.